Bright Minds Biosciences Stock Performance
| DRUG Stock | USD 34.03 1.91 5.31% |
The firm shows a Beta (market volatility) of -0.48, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Bright Minds are expected to decrease at a much lower rate. During the bear market, Bright Minds is likely to outperform the market. At this point, Bright Minds Biosciences has a negative expected return of -0.0735%. Please make sure to confirm Bright Minds' maximum drawdown, as well as the relationship between the accumulation distribution and price action indicator , to decide if Bright Minds Biosciences performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days Bright Minds Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Bright Minds is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
| Begin Period Cash Flow | 6.7 M |
Bright |
Bright Minds Relative Risk vs. Return Landscape
If you would invest 3,918 in Bright Minds Biosciences on November 27, 2024 and sell it today you would lose (438.00) from holding Bright Minds Biosciences or give up 11.18% of portfolio value over 90 days. Bright Minds Biosciences is currently does not generate positive expected returns and assumes 5.1148% risk (volatility on return distribution) over the 90 days horizon. In different words, 45% of stocks are less volatile than Bright, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Bright Minds Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Bright Minds' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Bright Minds Biosciences, and traders can use it to determine the average amount a Bright Minds' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0144
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | DRUG |
Estimated Market Risk
| 5.11 actual daily | 45 55% of assets are more volatile |
Expected Return
| -0.07 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.01 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Bright Minds is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Bright Minds by adding Bright Minds to a well-diversified portfolio.
Bright Minds Fundamentals Growth
Bright Stock prices reflect investors' perceptions of the future prospects and financial health of Bright Minds, and Bright Minds fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Bright Stock performance.
| Return On Equity | -0.52 | ||||
| Return On Asset | -0.29 | ||||
| Current Valuation | 212.51 M | ||||
| Shares Outstanding | 6.99 M | ||||
| Price To Book | 6.24 X | ||||
| EBITDA | (7.28 M) | ||||
| Cash And Equivalents | 8.64 M | ||||
| Cash Per Share | 0.71 X | ||||
| Total Debt | 118.96 K | ||||
| Book Value Per Share | 1.37 X | ||||
| Cash Flow From Operations | (1.85 M) | ||||
| Earnings Per Share | (0.45) X | ||||
| Total Asset | 6.1 M | ||||
| Retained Earnings | (34.35 M) | ||||
About Bright Minds Performance
By analyzing Bright Minds' fundamental ratios, stakeholders can gain valuable insights into Bright Minds' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Bright Minds has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Bright Minds has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Bright Minds Biosciences Inc., a pre-clinical biosciences company, develops 5-HT medicines to improve the lives of patients with severe and life-altering diseases. The company was incorporated in 2019 and is headquartered in Vancouver, Canada. Bright Minds is traded on NASDAQ Exchange in the United States.Things to note about Bright Minds Biosciences performance evaluation
Checking the ongoing alerts about Bright Minds for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Bright Minds Biosciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Bright Minds generated a negative expected return over the last 90 days | |
| Bright Minds has high historical volatility and very poor performance | |
| Bright Minds has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (2.8 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Bright Minds Biosciences currently holds about 8.64 M in cash with (1.85 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.71. | |
| Roughly 27.0% of the company shares are held by company insiders |
- Analyzing Bright Minds' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Bright Minds' stock is overvalued or undervalued compared to its peers.
- Examining Bright Minds' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Bright Minds' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Bright Minds' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Bright Minds' stock. These opinions can provide insight into Bright Minds' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Bright Stock analysis
When running Bright Minds' price analysis, check to measure Bright Minds' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bright Minds is operating at the current time. Most of Bright Minds' value examination focuses on studying past and present price action to predict the probability of Bright Minds' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bright Minds' price. Additionally, you may evaluate how the addition of Bright Minds to your portfolios can decrease your overall portfolio volatility.
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |